Skip to main content

The i-ACT™ in Obesity educational intervention: a pilot study on improving Canadian family physician care in obesity medicine

Abstract

Background

Obesity is a chronic problem in Canada and although the Canadian Medical Association recognizes obesity as a disease, health care professionals (HCPs) are not necessarily proactively managing it as one. This study aimed to assess current obesity management knowledge and practices of Canadian family physicians (FPs) and evaluate the feasibility of an online self-directed learning platform, i-ACT™ in Obesity, in delivering learning and changing practice intentions to advance obesity management.

Methods

i-ACT™ in Obesity is an online self-directed learning program designed by Canadian obesity medicine experts to provide individualized learning curricula to participants. One hundred FPs, with an interest in weight management and managing patients with obesity, were recruited across Canada to participate in a pilot study. FP education was delivered in a stepwise manner. Each participant completed a practice profile assessment to determine knowledge gaps and educational needs. Learners then watched didactic videos across disciplines on topics assigned to their curriculum by the program algorithm based on the relative difference between indicated and desired current knowledge. FPs also completed 10 retrospective patient assessments to assess clinical management practices and planned behaviour change. Feasibility, acceptability, and satisfaction of the learning program were assessed to formulate the rationale for a more widespread deployment in the future. Survey responses and related data were analyzed using comparative measures and descriptive statistics.

Results

The program was piloted by ninety-one Canadian FPs, where 900 patients were assessed. FPs showed distinct differences between their current and desired levels of comfort in a variety of obesity-related topics. Participation was associated with an intention to use more obesity treatment interventions moving forward. The program received an overall satisfaction rating of 8.6 out of 10 and 100% of the evaluators indicated that they would recommend it to their colleagues.

Conclusion

The program was overall well received and successfully changed obesity management intentions among participating FPs, thus setting the stage for a larger more comprehensive study to examine the efficacy of i-ACT™ in Obesity in addressing knowledge gaps and advancing evidence-based, guidelines-aligned approach to obesity treatment.

Peer Review reports

Background

Obesity has remained a chronic disease in Canada and elsewhere in the world for decades. According to the World Health Organization, obesity affects more than 650 million adults worldwide [1], while in Canada, about 7.3 million adults—about a fifth of the Canadian population—are currently classified as having obesity (body-mass index [BMI] ≥ 30 kg/m2) [2]. Direct costs associated with overweight and obesity were estimated in 2010 to represent 4.1% of total Canadian health care expenditures [3]. The percentage of Canadians classified as having obesity increased every year between 2009 and 2014 [4].

Unfortunately, despite these alarming numbers and the recognition by the Canadian Medical Association of obesity as a disease [5], health care professionals (HCPs) in Canada and elsewhere are not necessarily proactively managing this chronic disease, presenting a challenge for patients with obesity. For example, an American study noted that weight management counselling in primary care decreased between 2008-09 and 2012-13 [6]. The 2011 State of Obesity Care in Canada Evaluation Registry (SOCCER) study found that many Canadian HCPs did not raise the issue of weight with their patients affected by overweight and obesity [7]; similarly, a 2012 Canadian survey found that only 30% of patients with overweight or obesity were advised on weight management if they did not specifically request it [8].

Currently, the majority of Canadian HCPs do believe they have a role to play in this arena. The Canadian Awareness, Care and Treatment In Obesity MaNagement (ACTION) study, published in 2019, surveyed 2,000 people with obesity, 395 HCPs, and 150 employers on perceptions, attitudes, and perceived barriers to obesity management [9]. Although only 21% of people with obesity agreed that it was their HCP’s responsibility to actively contribute to their weight management efforts, 74% of HCPs surveyed agreed that they have a responsibility to help people with obesity to manage their weight.

This does not mean that Canadian patients are necessarily getting the help they need. Although HCPs in the ACTION study reported discussing weight with 72% of their patients in need of weight management, only 54% of the people with obesity surveyed reported having such discussions in the previous five years. Of those individuals who did report discussing weight, only 48% reported getting an obesity diagnosis from a qualified HCP, and only 28% reported having a weight-related call or follow-up scheduled. Moreover, although the 2020 Canadian guidelines recommend three pillars of obesity medicine: pharmacotherapy, psychological interventions, and bariatric surgery [10], in the SOCCER study, Canadian physicians did not recommend any single anti-obesity management strategy in more than 50% of their patients [7]. These studies did not suggest nor develop tools for improving physicians’ involvement in or knowledge about weight management, although it has been established that educational interventions for physicians and patients can make a difference in this field [11, 12].

The purpose of this study was to assess current obesity management knowledge and practices of Canadian family physicians (FPs) and evaluate the feasibility of using an online self-directed learning platform to deliver learning and change practice intentions. For this purpose, we developed a comprehensive online education platform called Integrated Approaches to Change Treatment in Obesity (i-ACT™ in Obesity) designed to evoke behaviour change and advance the clinical management of people with obesity. i-ACT™ in Obesity is an involved-learning platform developed to empower Canadian FPs with the knowledge and practical skills needed to improve the health outcomes of patients with obesity. In this pilot study we assessed the feasibility, acceptability, and satisfaction of the learning program for a more widespread deployment in the future.

Methods

Ethics approval and consent to participate

The Tri-Council Policy Statement (TCPS2) is a Canadian guideline for the ethical conduct of research involving humans and/or human biological materials. TCPS2 article 2.4 specifies that "REB review is not required for research that relies exclusively on secondary use of anonymous information, or anonymous human biological materials, so long as the process of data linkage or recording or dissemination of results does not generate identifiable information”.

A formal ethics committee review was not sought nor required for this program as it was developed for educational purposes only and was not intended to measure therapeutic outcomes. Participating FPs collected patient information through electronic medical records and chart audits to identify trends for self-reflection and educational purposes only. No identifying patient information was collected, and all FP- and patient-related data collected from the surveys were anonymized, prior to use in the study and is considered secondary use. Participants provided their consent to participate in the program by signing a participant agreement form.

Data were collected and analyzed in aggregate and were not linked to individual participant survey responses or consent information. The data analyzed in this manuscript is based solely on the use of the anonymized data and the results presented does not generate identifiable information. The manuscript was prepared in accordance with the Consolidated Standards of Reporting Trials (CONSORT) 2010 Checklist for pilot or feasibility studies.

Design and setting

Although clinical practice guidelines are invaluable for bridging the gap between clinical practice and scientific evidence, guidelines are often poorly implemented into physician practices. Physician adherence is often limited by lack of awareness, lack of familiarity, and low self-efficacy. This results in a discrepancy between guideline recommendations and physician behavior. Knowledge Transfer Initiatives such as the Head to Heart initiative have been successfully used to elicit point-of-care knowledge transfer and facilitate guideline adherence [13]. We, therefore, set out to design an educational program to bridge the gap between obesity treatment guideline recommendations and clinical practice. The program was sponsored by Bausch Health Canada, and the continuing medical education company CTC Communication Corporation managed content development with the planning committee directly. Four Canadian experts in obesity medicine were identified as planning committee members: an endocrinologist, two internal medicine specialists, and one FP. Since educational topics in obesity are diverse and physicians’ learning requirements differ, the planning committee determined that the program should be individualized to the learner’s needs. They therefore designed a program to deliver education in a stepwise approach that included numerous touchpoints (Supplementary Fig. 1; Table 1) that involved both self-teaching and interactions with mentors and obesity experts. The pilot phase of the project invited 100 Canadian FPs to determine the feasibility, acceptability, and satisfaction of the program with an expansion planned after evaluation of the pilot.

Table 1 Linear steps involved in education delivery in i-ACT™ in Obesity

Program operation and evaluation

Between August 2019 and August 2020, Canadian FPs were actively recruited (via e-mail and postcard invitations) to participate. FPs were identified and recruited based on their interest in obesity management and participation in previous obesity management-related programs and initiatives. Recruited FPs included those with interest in weight management, those currently active or not active in managing patients with obesity, and FPs representative of all key regions across Canada. Out of 100 invited FPs, 91 enrolled to participate in the study. After enrollment, education was delivered in a stepwise approach as shown in Table 1.

To collect baseline characteristics on FP knowledge gaps and to determine educational needs, practice profile surveys were developed and administered to FPs via the i-ACT™ in Obesity platform. To assess current management practices and planned changes to patient management, participating FPs also completed a patient assessment survey, which was a self-directed retrospective patient chart review for 10 of their patients with obesity. To be considered for the chart review, FPs were required to select patients aged 18 years or older, who had a BMI ≥30 kg/m2 or a BMI ≥27 kg/m2 with obesity-related comorbidities. Participating FPs retrieved patient information through electronic medical records and chart audits. Deidentified patient information was entered by the participating FPs into the platform and aggregated data was obtained for analysis. Prior to survey and platform launch, user acceptance testing was conducted and assessed through platform review and testing by the steering committee members.

After the program ended, 36 out of 91 participants voluntarily evaluated the five elements of the program (practice profile, educational videos, patient assessments, plan of action and focus group) in terms of what they added to the participant’s education experience. Program elements were evaluated quantitatively through ratings and qualitatively through open ended questions. Evaluators were also asked to rate the program overall and whether they would recommend it to a colleague.

Data and statistical analysis

Data were collected from August 2019 to October 2020 and analysis was conducted using Microsoft Excel: demographic characteristics (FPs and patients), levels of comfort in discussing obesity topics (current vs. desired), and changes in obesity management interventions use (first vs. second self-assessment response) were analyzed using comparative measures. For dichotomous (yes/no) questions, the proportion of respondents who answered “Yes” were examined. For Likert-type questions (scored from 1 [strongly disagree] to 5 [strongly agree] or 1 [very poor] to 5 [excellent]), the weighted average for each ranking was calculated. Survey responses using standard descriptive statistics in Microsoft Excel were examined. Descriptive statistics such as mean, percentage, distribution, and range were analyzed by CTC Communications Corporation and reviewed by the planning committee.

Results

Primary results

Ninety-one practice and 900 patient profiles were completed by FPs from across Canada (Table 2) between August 2019 and October 2020. There were distinct differences (as shown by differences on a five-point Likert scale) between the FPs’ current and desired levels of comfort with obesity-related topics frequently discussed with their patients (Fig. 1), demonstrating the need for education around this subject.

Table 2 Family physician characteristics
Fig. 1
figure 1

Current versus desired levels of comfort in discussing obesity topics with patients as reported during the baseline needs assessment (N = 91)

Family physician profiles before intervention

Prior to completing the i-ACT in Obesity educational intervention, FPs did not consistently address weight loss with their patients with obesity. When a patient with overweight presented to their practice, 29% of FPs “always” and 54% “often” actively approached the topic of weight, while 16% of FPs “sometimes” and 1% “rarely” approached the topic. No FP indicated they “never” approached the topic of weight.

Interventions recommended to patients with obesity by FPs tended to focus on the “eat less and exercise more” approach. Eighty-six percent of FPs often recommended increased physical activity for obesity management, 60% often recommended calorie reduction, 57% often recommended a specific diet, and 32% often recommended the use of a food journal.

Patient profiles

In the patients (Table 3) assessed in this program, comorbidities related to obesity were common, reported by 90% of patients (n = 810). Of those patients, 67% had hypertension, 65% had type 2 diabetes, and 88% had dyslipidemia. Of the patients with one or more comorbidities, 74% were experiencing depression and 64% were experiencing anxiety.

Table 3 Patient characteristics

FPs reported that 91% of their patients understood the importance of weight reduction, but only 66% of patients had a very good or satisfactory knowledge of obesity. FPs indicated that they explained the concept of obesity as a chronic disease to 88% of their patients, however, only 63% of their patients understood this concept.

The interventions for weight management previously used by these patients were primarily focused on diet and exercise. Forty-seven percent of patients had tried dietary changes, 37% had tried physical activity changes, and 12% had tried pharmacotherapy. Of the 108 patients who had tried pharmacotherapy, 44% had tried liraglutide, 27% had tried naltrexone/bupropion, 15% had tried orlistat, and 12% had tried other weight management pharmacotherapy.

Patients reported significant barriers to an obesity management plan. Those most frequently cited included lack of adherence (20%), lack of support (12%), lifestyle changes being too restrictive (14%), dislike for lifestyle changes (13%), lack of time (13%), and cost of treatment (10%).

FPs recommended a wide variety of interventions to help their patients lose weight (Fig. 2). Weight management plans incorporated dietary changes (29%), physical activity (27%), pharmacotherapy (22%), referral to a dietitian and/or kinesiologist (15%), referral for bariatric consult (4%), and other interventions (2%).

Fig. 2
figure 2

Changes in intervention use. A Responses to “What interventions have you ever used with your patient?” (first self-assessment, N = 91); B Responses to “What interventions are you considering today?” (second self-assessment, N = 900)

When pharmacotherapy was recommended (in 198 patients), 59% of patients were recommended naltrexone/bupropion and 38% were recommended liraglutide. Of the patients referred for a bariatric consult, 52% had a BMI ≥ 40 kg/m2 (the recommended minimum BMI for bariatric surgery).

Changes in FP intentions in providing obesity-related care

Participation in the i-ACT™ in Obesity program was associated with the intention to use more obesity treatment interventions, including pharmacotherapy, dietary and physical changes, and bariatric surgery referral. As part of the patient assessment step, FPs reported a mean of 2.0 interventions each patient had previously tried for obesity. When asked if they intended to make any changes moving forward, FPs indicated they intended to use a mean of 2.7 interventions. Participation was also associated with the intension to recommend fewer dietary changes and more pharmacotherapy and referrals (Fig. 2). As a result of the i-ACT™ in Obesity program, almost a quarter of participating FPs’ patients will now be considered for pharmacotherapy.

Program satisfaction evaluation

Out of the 91 FPs who participated in the study, 36 voluntarily completed the program satisfaction evaluation component. Rated on a Likert scale from 1 to 5 (where 5 meant “strongly agree that this element added value to my educational experience”), the five elements of the program scored between 4.2 and 4.7. Overall, the program was rated at 8.6 points out of a possible 10 (where 1 meant “poor” and 10 meant “excellent”) (Fig. 3). All 36 evaluators said that they would recommend the program to a colleague.

Fig. 3.
figure 3

FP satisfaction with the i-ACT™ in Obesity program. Response to “How would you rate the program overall?” (Rate from 1 to 10, where 1= Poor, 5 = Neutral, and 10 = Excellent; N=36).

Discussion

This pilot study aimed to assess current obesity management knowledge and practices of Canadian FPs and evaluate the feasibility, acceptability, and satisfaction of the i-ACT™ in Obesity educational program, in delivering learning and changing practice intentions to advance obesity management. Here, we identified a gap between current FP knowledge and the desired knowledge required for effectively managing patients with obesity. The i-ACT™ in Obesity learning program was well received and successfully changed obesity management intentions among participating FPs, indicating further research is warranted. This pilot study provided encouraging feasibility and satisfaction outcomes which can be used as a framework for a larger randomized controlled trial (RCT) efficacy study in the future.

The i-ACT™ in Obesity is a learning platform developed to provide individualized learning curricula to FPs by facilitating involved learning and self-reflection while: 1) improving the understanding of obesity as a chronic pathology and its impact on the patient’s journey, 2) advancing management of patients with obesity in Canadian primary care, and 3) providing opportunities for collaboration with peers and expert mentors. Canadian FPs showed distinct differences between their current and desired levels of comfort with a variety of obesity-related topics frequently discussed with patients. Before the program intervention, participating FPs tended to focus on the “eat less and exercise more” approach as their management strategy for patients with obesity. After the intervention, participants changed their intentions toward obesity management, intending to recommend fewer dietary changes and more pharmacotherapy and specialist referrals.

Forty-four percent of participating FPs reported in their original self-assessments that they recommended antiobesity medications often or very often, and 12% of the patients seen by these FPs had already tried pharmacotherapy for weight management. This suggests that the participants in i-ACT™ in Obesity began the program as unusually high users of obesity-targeted pharmacotherapy. By contrast, only 12% of HCPs in the 2019 ACTION Canada study reported discussing prescription medication with their patients with obesity [9]. This difference may be accounted for by the fact that the i-ACT™ in Obesity participants were selected for their interest in obesity management and likely volunteered to participate due to their interest in this topic.

Despite being developed before the publication of the new Canadian obesity guidelines, the i-ACT™ in Obesity intervention appears to have notably changed obesity management intentions among participating FPs, moving them away from an “eat less and exercise” approach and toward a more evidence-based, guidelines-aligned approach involving pharmacotherapy and referrals to dietitians, kinesiologists, and bariatric specialists (10). The i-ACT™ in Obesity platform is now available to physicians alongside the guidelines, providing a wider range of options for increased learning and confidence.

It has been shown in fields other than obesity that education of HCPs improves their knowledge, confidence, and enthusiasm for management of specific conditions [15]. Multimedia- or Internet-based educational interventions have been shown to improve surgical performance [16] and the detection of child abuse by nurses [17]. Systematic reviews have shown that Web-based learning improved nurses’ knowledge and skills performance [18], and computer-assisted learning improved knowledge gain in orthodontic students [19]. Here we demonstrated the feasibility, acceptability, and satisfaction of the i-ACT™ in Obesity program in furthering FP knowledge of obesity management guidelines and changing clinical care intentions. We hope that i-ACT™ in Obesity will join a growing list of interventions aimed at disseminating important knowledge and skills in the field of obesity management. Our intention is to deploy this program to a wider range of physicians and evaluate its efficacy in driving behavioural changes in physicians as well as patients when it comes to obesity care and management.

Limitations

This educational intervention was conducted as a pilot study and due to the relatively small sample size of the participants, the characteristics, responses, and behaviour of the respondents may not be representative of the majority of Canadian FPs. Although our results appear to have notably changed obesity management intentions among participating physicians, a larger-scale study with more physicians (and patients) is needed to assess generalizability. It may also be valuable to include a follow-up period to assess practice changes following the program intervention to determine whether the planned changes were implemented. Moreover, this study utilized only one group with no comparator arm. Future improvements could include a RCT (comparing a control group with no intervention to one receiving the i-ACT™ in Obesity educational intervention) as well as a follow-up survey to determine efficacy, and impact on physician behaviours as well as an assessment of patient success.

There was some misalignment noted around FP explanations and patient beliefs—such as the difference seen between FPs’ communication that obesity is a chronic disease and their perception of patients’ understanding of that fact—perhaps suggesting that not all patients have confidence in their FPs’ explanations. Patient-reported characteristics, preferences, satisfaction, and health -outcomes were not considered in this pilot phase. Although clinical management of the patients may not differ significantly before or after the educational intervention, this possibility cannot be excluded. It may be of interest to include a self-reported patient assessment to the program to further address these differences.

Differences in FPs’ comfort levels with the various topics also suggested the existence of biases and possible paternalism, since the group perceived themselves to be very comfortable discussing the benefits of weight loss—something that physicians might lecture their patients about—but much less comfortable talking about the reasons patients do not want to discuss their weight with their doctor. Future research could explore whether there are additional evidence-informed strategies that would encourage more physicians to recognize and mitigate these biases.

Conclusions

i-ACTTM in Obesity is a comprehensive platform that delivers obesity education across a diverse range of topics, with educational interventions and content specific to a participating physician’s learning needs. It has demonstrated the ability to alter FPs’ intentions toward more evidence-based management of obesity, and we believe it may be used long-term as a valuable educational tool. We hope that use of this platform by additional physicians will both improve currently limited levels of physician knowledge and provide further data about Canadian family physician management of patients with obesity.

Availability of data and materials

Anonymized datasets used and analyzed during the current study may be available upon reasonable request to the corresponding author.

Abbreviations

ACTION:

Awareness, Care and Treatment In Obesity MaNagement

ADHD:

Attention deficit–hyperactivity disorder

BMI:

Body-mass index

CONSORT:

Consolidated Standards of Reporting Trials

FP:

Family physician

GERD:

Gastroesophageal reflux disease

HCP:

Health care professionals

i-ACT™:

Integrated Approaches to Change Treatment

NAFLD:

Non-alcoholic fatty liver disease

OA:

Osteoarthritis

OMEC:

Obesity Medicine Education Collaborative

OSA:

Obstructive sleep apnea

PCOS:

Polycystic ovary syndrome

RCT:

Randomized controlled trial

SOCCER:

State of Obesity Care in Canada Evaluation Registry

References

  1. World Health Organization [Internet]. Obesity and Overweight Fact Sheet. Updated April 1, 2020 [cited 2020 Jul 16]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

  2. Statistics Canada [Internet]. Overweight and Obese Adults, 2018. Released June 25, 2019 [cited 2020 Jul 16]. Available from: https://www150.statcan.gc.ca/n1/en/pub/82-625-x/2019001/article/00005-eng.pdf.

  3. Anis AH, Zhang W, Bansback N, Guh DP, Amarsi Z, Birmingham CL. Obesity and overweight in Canada: an updated cost-of-illness study. Obes Rev. 2010;11(1):31–40.

    Article  CAS  Google Scholar 

  4. Canadian Obesity Network-Réseau canadien en obésité. Report Card on Access to Obesity Treatment for Adults in Canada 2017. Edmonton: Canadian Obesity Network Inc; 2017.

    Google Scholar 

  5. Canadian Medical Association [Internet]. Obesity as a Chronic Medical Disease; c2019 [cited 2020 Nov 30]. Available from: https://policybase.cma.ca/en/permalink/policy11700.

  6. Fitzpatrick SL, Stevens VJ. Adult obesity management in primary care, 2008–2013. Prev Med (Baltim). 2017;99:128–33.

    Article  Google Scholar 

  7. Padwal RS, Damjanovic S, Schulze KM, Lewanczuk RZ, Lau DC, Sharma AM. Canadian physicians’ use of antiobesity drugs and their referral patterns to weight management programs or providers: the SOCCER study. J Obes. 2011;2011:686521.

    Article  CAS  Google Scholar 

  8. Kirk SF, Tytus R, Tsuyuki RT, Sharma AM. Weight management experiences of overweight and obese Canadian adults: findings from a national survey. Chronic Dis Inj Can. 2012;32(2):63–9.

    Article  CAS  Google Scholar 

  9. Sharma AM, Bélanger A, Carson V, Krah J, Langlois M-F, Lawlor D, et al. Perceptions of barriers to effective obesity management in Canada: results from the ACTION study. Clin Obes. 2019;9(5):e12329.

    Article  Google Scholar 

  10. Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020;192(31):E875–91.

    Article  Google Scholar 

  11. Flodgren G, Gonçalves-Bradley DC, Summerbell CD. Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity. Cochrane Database Syst Rev. 2017;11(11):CD000984.

    PubMed  Google Scholar 

  12. Rigas G, Golden A, Nadglowski J, Tomaszewski KJ, Metha M, Stevenin B, Look M, Dixon J. The importance of good dialogue between healthcare professionals and people with obesity. Obes Res Clin Pract. 2019;13:250–251.

  13. Menzies S, Duz J, Kinch R. Knowledge transfer at point of care: investigating new strategies for implementing guideline recommendations. J Contin Educ Health Prof. 2015;35(Suppl 1):S22–3 14.

    Article  Google Scholar 

  14. Kushner RF, Horn DB, Butsch WS, Brown JD, Duncan K, Fugate CS, et al. Development of obesity competencies for medical education: a report from the Obesity Medicine Education Collaborative. Obesity (Silver Spring). 2019;27(7):1063–7.

    Article  Google Scholar 

  15. Singh M, Short D, Manzie J, Trundle A, Scott P. Impact of medical education program on HCPs and patient understanding of COPD. Eur Respir J. 2014;44(Suppl 58):P2802.

    Google Scholar 

  16. Pape-Koehler C, Immenroth M, Sauerland S, Lefering R, Lindlohr C, Toaspern J, et al. Multimedia-based training on Internet platforms improves surgical performance: a randomized controlled trial. Surg Endosc. 2013;27(5):1737–47.

    Article  Google Scholar 

  17. Smeekens AEFN, Broekhuijsen-van Henten DM, Sittig JS, Russel IMB, ten Cate OTJ, Turner NM, et al. Successful e-learning programme on the detection of child abuse in Emergency Departments: a randomised controlled trial. Arch Dis Child. 2011;96(4):330–4.

    Article  CAS  Google Scholar 

  18. Du S, Liu Z, Liu S, Yin H, Xu G, Zhang H, et al. Web-based distance learning for nurse education: a systematic review. Int Nurs Rev. 2013;60(2):167–77.

    Article  CAS  Google Scholar 

  19. Al-Jewair TS, Azarpazhooh A, Suri S, Shah PS. Computer-assisted learning in orthodontic education: a systematic review and meta-analysis. J Dent Educ. 2009;73(6):730–9.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

The i-ACT™ in Obesity program and development of the publication was supported by Bausch Health Companies Inc.

Author information

Authors and Affiliations

Authors

Contributions

Sean Wharton, David Macklin, and Marie-Philippe Morin contributed to the study design, survey development, and provided feedback on data analyses and interpretation and manuscript development at all stages. Stuart Menzies and Laura Garofalo managed the operational elements of this program, including but not limited to survey formatting and data analyses. Michelle A. Francisco and Carol Thomas drafted this manuscript and incorporated coauthor feedback and managed manuscript revisions. Jessica Blavignac and Maxime Barakat were provided the opportunity to review the study design, aggregate associated data, and read the manuscript for scientific accuracy. All authors contributed to the critical revision of the manuscript for important intellectual content, approved the final version to be published, and agreed to be accountable for all aspects of the work.

Corresponding author

Correspondence to Michelle A. Francisco.

Ethics declarations

Ethics approval and consent to participate

The Tri-Council Policy Statement (TCPS2) is a Canadian guideline for the ethical conduct of research involving humans and/or human biological materials. TCPS2 article 2.4 specifies that "REB review is not required for research that relies exclusively on secondary use of anonymous information, or anonymous human biological materials, so long as the process of data linkage or recording or dissemination of results does not generate identifiable information”.

A formal ethics committee review was not sought nor required for this program as it was developed for educational purposes only and was not intended to measure therapeutic outcomes. Participating physicians collected patient information through electronic medical records and chart audits to identify trends for self-reflection and educational purposes only. No identifying patient information was collected, and all physician- and patient-related data collected from the surveys were anonymized, prior to use in the study and is considered secondary use. Participants provided their consent to participate in the program by signing a participant agreement form.

Data were collected and analyzed in aggregate and were not linked to individual participant survey responses or consent information. The data analyzed in this manuscript is based solely on the use of the anonymized data and the results presented does not generate identifiable information. The manuscript was prepared in accordance with the Standards for QUality Improvement Reporting Excellence in Education (SQUIRE-EDU) statement for quality improvement studies in education.

Consent for publication

Not applicable.

Competing interests

The i-ACT™ in Obesity program and development of the publication was supported by Bausch Health Canada Inc. Maxime Barakat and Jessica Blavignac are employees of Bausch Health Canada Inc. Sean Wharton, David Macklin, Marie-Philippe Morin, Stuart Menzies, Laura Garofalo, Michelle A. Francisco and Carol Thomas received direct or indirect funding from Bausch Health Companies Inc.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Supplementary Figure 1.

Participants of i-ACT™ in Obesity.

Additional file 2: Supplementary file 1.

Titles and learning objectives of 11 didactic educational videos included in i-ACT™ in Obesity.

Additional file 3: Supplementary file 2.

Algorithm for determining learner’s i-ACT™ in Obesity video curriculum.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wharton, S., Macklin, D., Morin, MP. et al. The i-ACT™ in Obesity educational intervention: a pilot study on improving Canadian family physician care in obesity medicine. BMC Prim. Care 23, 101 (2022). https://doi.org/10.1186/s12875-022-01715-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12875-022-01715-w

Keywords